InvestorsHub Logo
Followers 129
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

Re: None

Thursday, 02/27/2020 2:42:45 PM

Thursday, February 27, 2020 2:42:45 PM

Post# of 647880
BIXT = 0.48--HOT CORONA GEM and still undiscovered market cap only $29 million has a potential late stage drug against Coronavirus

Top Coronavirus Stocks backed by Scientific Evidence ... Posted on February 27, 2020
https://insiderfinancial.com/top-coronavirus-stocks-backed-by-scientific-evidence/179657/

"Just recently Bioxytran Inc. (OTCMKT: BIXT) announced it was seeking to partner with a drug company to treat COVID-19 using its lead compound BXT-25. Bioxytran is developing an oxygen transport molecule that 5000 times smaller than a red blood cell. It’s molecule is based off of Hemopure which is an FDA approved blood substitute for veterinary use. The drug is thought to be safe and is designed to get rid of the Nitric Oxygen scavenging which effected the approval trajectory of Hemopure. The drug is a product of over 30 years and $500 million of drug development. As an oxygen carrier it can treat literally any disease including ARDS and stroke. In ARDS the theoretical mechanism is that BXT-25 would be part of the blood plasma that leaks out into the lungs getting much closer to the air so that it is able to capture the oxygen and recirculate it. Unless they are able to get a quick approval and funding this preclinical asset may be too late to join the fight regardless of the vastness of their platform technology to deliver oxygen without a hypobaric chamber."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.